Dafu Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dafu Zhang has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
Yaxue Chen
Department of Nursing, Dazhou Vocational and Technical College, Dazhou, China
3 shared publications- Zhenhui Li
Department of Radiology, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Yunnan Cancer Center, Kunming, China
3 shared publications Hongjiang Pu
Department of Radiology, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Yunnan Cancer Centre, Kunming, China
2 shared publicationsXiaolin Pang
Department of Radiotherapy, The Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China
2 shared publicationsZhenhui Li
Yunnan Cancer Hospital
2 shared publications- Zongsheng Pu
Department of Radiology, The Third People's Hospital of Honghe Hani and Yi Autonomous Prefecture, Gejiu, 661000, China
2 shared publications
Latest Publications
- 6 September 2025
- Published by Elsevier in Clinical Radiology
- Vol. 90, 107077
A CT radiomics-based machine learning model for predicting high-grade pathological components in stage IA lung adenocarcinoma: a two-center study
- 6 September 2025
- Published by Elsevier in Clinical Radiology
- Vol. 90, 107077
A CT radiomics-based machine learning model for predicting high-grade pathological components in stage IA lung adenocarcinoma: a two-center study
- 24 May 2025
- Published by SAGE Publications in The Neuroradiology Journal
- Vol. 39 (1) , 96-104
Differential diagnosis of intracranial solitary fibrous tumor and high-grade meningioma based on CT and MRI features
Background: ISFT and HGM exhibit similar imaging characteristics, but their distinct behaviors and treatments necessitate accurate preoperative imaging for optimal management. Purpose: To evaluate conventional CT and MRI in differentiating ISFT from HGM. Methods: Retrospective analysis of clinical data, CT, and MRI images from 31 ISFT and 50 HGM patients confirmed by pathology. Various imaging features were examined, including tumor size, shape (lobulated or round), base width (narrow or broad), presence of cystic necrosis, calcification, signal intensity on T1- and T2-weighted MRI, intravascular flowing-void signs, peritumoral edema, CT attenuation values on non-enhanced and enhanced scans, and adjacent bone destruction. Chi-square tests, t-tests, ROC curves, and multivariate logistic regression were used to establish predictive models. A nomogram illustrated the final model. Results: ISFT onset age was ≤48.5 years, with a maximum tumor diameter of ≥4.5 cm. Features included lobulated appearance, narrow base, cystic necrosis, absence of calcification, low T1-weighted MRI signal, intravascular flowing-void signs, peritumoral edema, CT value ≤51.7 Hu on non-enhanced and ≥107.6 Hu on enhanced scans, and adjacent bone destruction. Combining tumor diameter, vascular flowing void, enhanced CT value, and absence of calcification yielded 92.0% sensitivity and 90.3% specificity for ISFT diagnosis. Conclusion: Age and imaging characteristics effectively differentiate ISFT from HGM, particularly with a tumor diameter ≥4.5 cm, vascular flowing-void signals, absence of calcification, and enhanced CT value ≥107.6 Hu. A nomogram shows good predictive efficacy.
- 24 May 2025
- Published by SAGE Publications in The Neuroradiology Journal
- Vol. 39 (1) , 96-104
Differential diagnosis of intracranial solitary fibrous tumor and high-grade meningioma based on CT and MRI features
Background: ISFT and HGM exhibit similar imaging characteristics, but their distinct behaviors and treatments necessitate accurate preoperative imaging for optimal management. Purpose: To evaluate conventional CT and MRI in differentiating ISFT from HGM. Methods: Retrospective analysis of clinical data, CT, and MRI images from 31 ISFT and 50 HGM patients confirmed by pathology. Various imaging features were examined, including tumor size, shape (lobulated or round), base width (narrow or broad), presence of cystic necrosis, calcification, signal intensity on T1- and T2-weighted MRI, intravascular flowing-void signs, peritumoral edema, CT attenuation values on non-enhanced and enhanced scans, and adjacent bone destruction. Chi-square tests, t-tests, ROC curves, and multivariate logistic regression were used to establish predictive models. A nomogram illustrated the final model. Results: ISFT onset age was ≤48.5 years, with a maximum tumor diameter of ≥4.5 cm. Features included lobulated appearance, narrow base, cystic necrosis, absence of calcification, low T1-weighted MRI signal, intravascular flowing-void signs, peritumoral edema, CT value ≤51.7 Hu on non-enhanced and ≥107.6 Hu on enhanced scans, and adjacent bone destruction. Combining tumor diameter, vascular flowing void, enhanced CT value, and absence of calcification yielded 92.0% sensitivity and 90.3% specificity for ISFT diagnosis. Conclusion: Age and imaging characteristics effectively differentiate ISFT from HGM, particularly with a tumor diameter ≥4.5 cm, vascular flowing-void signals, absence of calcification, and enhanced CT value ≥107.6 Hu. A nomogram shows good predictive efficacy.
- 12 March 2025
- Published by Elsevier in Asian Journal of Psychiatry
- Vol. 107, 104445
Structural alterations after repetitive transcranial magnetic stimulation in depression and the link to neurotransmitter profiles
- 12 March 2025
- Published by Elsevier in Asian Journal of Psychiatry
- Vol. 107, 104445
Structural alterations after repetitive transcranial magnetic stimulation in depression and the link to neurotransmitter profiles
- Open Access
- 20 May 2022
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 37 (6) , 1411-1420
Significance of tumor deposits combined with lymph node metastasis in stage III colorectal cancer patients: a retrospective multi-center cohort study from China
Purpose: The study aimed to explore the value of tumor deposits in stage III colorectal cancer (CRC) and verify whether patients with more tumor deposit numbers have higher risk of recurrence. Methods: The retrospective cohort analysis was performed at two cancer centers of China. Stage III CRC patients who underwent radical resection at the center between April 2008 and February 2019 were identified. The Univariate/Multivariate Cox regression, Kaplan–Meier analysis, and PSM were recurrence-free survival (RFS) used. Results: Total 1080 stage III CRC patients (634 [58.7%] men; median [IQR] age, 60 [50–68] years) who underwent radical surgical resection were identified for inclusion in this study. Patients with tumor deposits had a 12.8% lower 3-year RFS (n = 236 [69.9%]) than the patients without tumor deposits (n = 844 [82.7%]) (P ≤ 0.0001). The 3-year RFS of patients with stage N2 (n = 335 [61.2%]) was 18.6% lower (P ≤ 0.0001) than the original cohort of patients with stage N1 (n = 745 [79.8%]), but it was similar to the RFS of patients with 4 or more tumor deposits plus lymph node metastases (n = 58 [61.4%]) (P = 0.91). The RFS for patients with 4 or more tumor deposits plus number of lymph node metastases (n = 58 [61.4%]) was 15.8% lower than the cohort of patients with 1–3 tumor deposits + number of lymph node metastases (n = 687 [77.2%]) (P = 0.001). Multivariate analysis confirmed that patients with 4 or more tumor deposits + the number of lymph node metastases (hazard ratio [HR], 1.88; 95% CI, 1.24–2.87) were independently associated with a shorter RFS. Conclusion: The number of tumor deposits is an indicator of poor postoperative prognosis. It is necessary to incorporate the number of tumor deposits combined with the number of lymph node metastases to stratify postoperative stratification of stage III CRC, which may provide a new theoretical basis for adjuvant therapy for patients with N1 stage CRC after surgery.
- 20 May 2022
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 37 (6) , 1411-1420
Open AccessSignificance of tumor deposits combined with lymph node metastasis in stage III colorectal cancer patients: a retrospective multi-center cohort study from China
Purpose: The study aimed to explore the value of tumor deposits in stage III colorectal cancer (CRC) and verify whether patients with more tumor deposit numbers have higher risk of recurrence. Methods: The retrospective cohort analysis was performed at two cancer centers of China. Stage III CRC patients who underwent radical resection at the center between April 2008 and February 2019 were identified. The Univariate/Multivariate Cox regression, Kaplan–Meier analysis, and PSM were recurrence-free survival (RFS) used. Results: Total 1080 stage III CRC patients (634 [58.7%] men; median [IQR] age, 60 [50–68] years) who underwent radical surgical resection were identified for inclusion in this study. Patients with tumor deposits had a 12.8% lower 3-year RFS (n = 236 [69.9%]) than the patients without tumor deposits (n = 844 [82.7%]) (P ≤ 0.0001). The 3-year RFS of patients with stage N2 (n = 335 [61.2%]) was 18.6% lower (P ≤ 0.0001) than the original cohort of patients with stage N1 (n = 745 [79.8%]), but it was similar to the RFS of patients with 4 or more tumor deposits plus lymph node metastases (n = 58 [61.4%]) (P = 0.91). The RFS for patients with 4 or more tumor deposits plus number of lymph node metastases (n = 58 [61.4%]) was 15.8% lower than the cohort of patients with 1–3 tumor deposits + number of lymph node metastases (n = 687 [77.2%]) (P = 0.001). Multivariate analysis confirmed that patients with 4 or more tumor deposits + the number of lymph node metastases (hazard ratio [HR], 1.88; 95% CI, 1.24–2.87) were independently associated with a shorter RFS. Conclusion: The number of tumor deposits is an indicator of poor postoperative prognosis. It is necessary to incorporate the number of tumor deposits combined with the number of lymph node metastases to stratify postoperative stratification of stage III CRC, which may provide a new theoretical basis for adjuvant therapy for patients with N1 stage CRC after surgery.
- Open Access
- 15 March 2022
- Published by Springer Nature in Research Square
A prediction model for risk factors of stage II to III colon cancer based on postoperative serum carcinoembryonic antigen and tumor deposition: a retrospective multicenter cohort study
Purpose: This study aimed to establish a recurrence risk prediction model composed of postoperative CEA combined with pathological features for postoperative recurrence risk stratification in stage II to III colon cancer. Methods: A retrospective analysis of 1,321 patients who underwent radical surgery for stage II/III colon cancer from April 2008 to January 2019. Cox proportional hazards regression model was used to analyze the independent recurrence prognostic factors of patients with recurrence-free survival (RFS). The recurrence risk score was established based on independent recurrence prognostic factors, and the Kaplan-Meier method was used to draw the patient's recurrence-free survival curve and overall survival (OS) curve.Results: The median follow-up period of all patients was 49.73 months. Multivariate analysis of COX proportional hazards model showed that postoperative CEA increased (HR, 2.0; 95% CI, 1.1-3.5), higher stage N (HR, 2.0; 95 % CI, 1.1-3.5), tumor deposition (HR, 2.0; 95% CI, 1.1-3.5) is independently associated with shorter RFS. The recurrence risk score is an independent stratified prognostic factor of RFS and OS.Conclusion: Based on postoperative CEA, N stage and tumor deposition positive are powerful predictors of recurrence survival and prognosis for patients with stage II to III colon cancer.
- 15 March 2022
- Published by Springer Nature in Research Square
Open AccessA prediction model for risk factors of stage II to III colon cancer based on postoperative serum carcinoembryonic antigen and tumor deposition: a retrospective multicenter cohort study
Purpose: This study aimed to establish a recurrence risk prediction model composed of postoperative CEA combined with pathological features for postoperative recurrence risk stratification in stage II to III colon cancer. Methods: A retrospective analysis of 1,321 patients who underwent radical surgery for stage II/III colon cancer from April 2008 to January 2019. Cox proportional hazards regression model was used to analyze the independent recurrence prognostic factors of patients with recurrence-free survival (RFS). The recurrence risk score was established based on independent recurrence prognostic factors, and the Kaplan-Meier method was used to draw the patient's recurrence-free survival curve and overall survival (OS) curve.Results: The median follow-up period of all patients was 49.73 months. Multivariate analysis of COX proportional hazards model showed that postoperative CEA increased (HR, 2.0; 95% CI, 1.1-3.5), higher stage N (HR, 2.0; 95 % CI, 1.1-3.5), tumor deposition (HR, 2.0; 95% CI, 1.1-3.5) is independently associated with shorter RFS. The recurrence risk score is an independent stratified prognostic factor of RFS and OS.Conclusion: Based on postoperative CEA, N stage and tumor deposition positive are powerful predictors of recurrence survival and prognosis for patients with stage II to III colon cancer.
- Open Access
- 1 March 2021
- Published by Taylor & Francis in Cancer Management and Research
- Vol. ume 13, 2643-2651
Relationship Between Preoperative and Postoperative Serum Carcinoembryonic Antigen and Prognosis of Patients with Stage I–III Rectal Cancer: A Retrospective Study of a Multicentre Cohort of 1022 Rectal Cancer Patients
Purpose: Based on a multi-centered and a large sample size, this study aims to analyze the relationship between preoperative and postoperative serum CEA and recurrence of rectal cancer without preoperative therapy. Methods: This retrospective cohort study enrolled stage I to III rectal cancer patients without preoperative therapy (N = 1,022) who received radical resection of rectal cancer from 2 hospitals in China. Based on the preoperative and postoperative serum carcinoembryonic antigen, the patients were subdivided into 3 groups ie, normal preoperative CEA (≤ 5.0 ng/mL, N = 627), elevated preoperative (> 5.0 ng/mL) but normalized postoperative CEA (normalized postoperative CEA, N = 255), as well as elevated preoperative and postoperative CEA (elevated postoperative CEA, N = 67). The generalized additive model was used to assess the relationship between carcinoembryonic antigen and the risk of recurrence. Further, the Cox regression model was used to evaluate the relationship between carcinoembryonic antigen and 3-year recurrence-free survival (RFS) after adjusting for potential confounders. Results: The 3-year RFS of patients with elevated postoperative CEA was 45.8% (95% CI, 35.2% − 59.5%), which was significantly lower compared to the other two groups of patients (normalized postoperative CEA: 75.9%, 95% CI, 70.8%-81.4%; and normal preoperative CEA: 84.9%, 95% CI, 82.2%-87.8%) (P < 0.001). Based on multivariable Cox model analysis, the elevated postoperative CEA was a prognostic factor for 3 years RFS (hazard ratio [HR], 3.08; 95% CI, 2.05– 4.66; P< 0.001). At the same time, normalized postoperative CEA was insignificantly correlated with 3-year RFS (HR, 1.38; 95% CI, 1.00– 1.92; P = 0.05) and was not an independent risk factor. Conclusion: We found that preoperative and postoperative serum CEA of rectal cancer patients were related to the 3-year recurrence-free survival rate. Moreover, the risk of recurrence in the normalized postoperative CEA group of patients was insignificantly different from that of the normalized preoperative CEA patients. Therefore, it is necessary to combine preoperative and postoperative CEA to predict the prognosis of patients with rectal cancer, rather than using it alone.
- 1 March 2021
- Published by Taylor & Francis in Cancer Management and Research
- Vol. ume 13, 2643-2651
Open AccessRelationship Between Preoperative and Postoperative Serum Carcinoembryonic Antigen and Prognosis of Patients with Stage I–III Rectal Cancer: A Retrospective Study of a Multicentre Cohort of 1022 Rectal Cancer Patients
Purpose: Based on a multi-centered and a large sample size, this study aims to analyze the relationship between preoperative and postoperative serum CEA and recurrence of rectal cancer without preoperative therapy. Methods: This retrospective cohort study enrolled stage I to III rectal cancer patients without preoperative therapy (N = 1,022) who received radical resection of rectal cancer from 2 hospitals in China. Based on the preoperative and postoperative serum carcinoembryonic antigen, the patients were subdivided into 3 groups ie, normal preoperative CEA (≤ 5.0 ng/mL, N = 627), elevated preoperative (> 5.0 ng/mL) but normalized postoperative CEA (normalized postoperative CEA, N = 255), as well as elevated preoperative and postoperative CEA (elevated postoperative CEA, N = 67). The generalized additive model was used to assess the relationship between carcinoembryonic antigen and the risk of recurrence. Further, the Cox regression model was used to evaluate the relationship between carcinoembryonic antigen and 3-year recurrence-free survival (RFS) after adjusting for potential confounders. Results: The 3-year RFS of patients with elevated postoperative CEA was 45.8% (95% CI, 35.2% − 59.5%), which was significantly lower compared to the other two groups of patients (normalized postoperative CEA: 75.9%, 95% CI, 70.8%-81.4%; and normal preoperative CEA: 84.9%, 95% CI, 82.2%-87.8%) (P < 0.001). Based on multivariable Cox model analysis, the elevated postoperative CEA was a prognostic factor for 3 years RFS (hazard ratio [HR], 3.08; 95% CI, 2.05– 4.66; P< 0.001). At the same time, normalized postoperative CEA was insignificantly correlated with 3-year RFS (HR, 1.38; 95% CI, 1.00– 1.92; P = 0.05) and was not an independent risk factor. Conclusion: We found that preoperative and postoperative serum CEA of rectal cancer patients were related to the 3-year recurrence-free survival rate. Moreover, the risk of recurrence in the normalized postoperative CEA group of patients was insignificantly different from that of the normalized preoperative CEA patients. Therefore, it is necessary to combine preoperative and postoperative CEA to predict the prognosis of patients with rectal cancer, rather than using it alone.
- Open Access
- 1 April 2017
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. ume 10, 2297-2303
Role of CT scan in differentiating the type of colorectal cancer
Objectives: Most colorectal cancers are classical adenocarcinomas (AC), and less frequent subtypes include mucinous adenocarcinomas (MAC) and signet-ring cell carcinomas (SC). The purpose of this study was to evaluate the computed tomography (CT) findings that can help to differentiate MAC and SC from AC. Methods: CT scans of 168 patients with pathologically proven MAC and 67 patients with pathologically proven SC were analyzed, and 220 patients with classical AC were also included as a control group. CT findings of the three groups were compared and contrasted in terms of the bowel involvement patterns, contrast enhancement patterns, and presence or absence of bowel obstruction, intratumoral calcification, pericolic fat infiltration, and local tumor extension to adjacent organs. Statistical analyses were made by using the one-way analysis of variance, least significant difference test, and Pearson’s chi-square test. Results: Compared with classical AC, the MAC showed more severe (6.29±2.69 cm vs 4.57±1.74 cm, PPPPPP=0.001) than AC, but SC tend to show more cases of concentric even bowel-wall thickening (67.2%); homogeneous contrast enhancement was most common in SC (PPP=0.190) and direct invasion of adjacent organs or metastasis (P=0.323) were not significantly different among them. Conclusion: Some radiological features by CT can be used to classify different colon tumor types.
- 1 April 2017
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. ume 10, 2297-2303
Open AccessRole of CT scan in differentiating the type of colorectal cancer
Objectives: Most colorectal cancers are classical adenocarcinomas (AC), and less frequent subtypes include mucinous adenocarcinomas (MAC) and signet-ring cell carcinomas (SC). The purpose of this study was to evaluate the computed tomography (CT) findings that can help to differentiate MAC and SC from AC. Methods: CT scans of 168 patients with pathologically proven MAC and 67 patients with pathologically proven SC were analyzed, and 220 patients with classical AC were also included as a control group. CT findings of the three groups were compared and contrasted in terms of the bowel involvement patterns, contrast enhancement patterns, and presence or absence of bowel obstruction, intratumoral calcification, pericolic fat infiltration, and local tumor extension to adjacent organs. Statistical analyses were made by using the one-way analysis of variance, least significant difference test, and Pearson’s chi-square test. Results: Compared with classical AC, the MAC showed more severe (6.29±2.69 cm vs 4.57±1.74 cm, PPPPPP=0.001) than AC, but SC tend to show more cases of concentric even bowel-wall thickening (67.2%); homogeneous contrast enhancement was most common in SC (PPP=0.190) and direct invasion of adjacent organs or metastasis (P=0.323) were not significantly different among them. Conclusion: Some radiological features by CT can be used to classify different colon tumor types.